Patent ID: 11872224
Assignee: TAIGEN BIOPHARMACEUTICALS CO. (BEIJING), LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 12:
13. The pharmaceutical composition according to claim 12, wherein the pharmaceutically acceptable polymer is polyvinylpyrrolidone/vinyl acetate copolymer, polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, methacrylic acid and methyl methacrylate copolymer, hydroxypropyl cellulose (HPC), hydroxypropyl methyl cellulose acetate succinate (HPMCAS), hydroxypropyl methyl cellulose phthalate (HPMCP), Polyethylene glycol (PEG), or Kollidon SR.